Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 10, 2011, Pages 626-633

  Wanninger, Josef ^a   Neumeier, Markus ^a   Hellerbrand, Claus ^a   Schacherer, Doris ^a   Bauer, Sabrina ^a   Weiss, Thomas S ^a   Huber, Hanna ^a   Schäffler, Andreas ^a   Aslanidis, Charalampos ^a   Schölmerich, Jürgen ^a   Buechler, Christa ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Activin A; Adiponectin; Hepatocyte; Lipid accumulation

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE RECEPTOR ANTAGONIST; FATTY ACID; FOLLISTATIN; OLEIC ACID; PALMITIC ACID; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BODY MASS; CELL LINE; CELL TRANSFORMATION; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG ACTIVITY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID STORAGE; LIVER CELL; LIVER INJURY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ACTIVINS; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; CELL LINE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; OLEIC ACID; PALMITIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 80051789319     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.11.001     Document Type: Article

References (45)

1. A.D. Clouston, J.R. Jonsson, and E.E. Powell Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others Clin. Liver Dis. 11 2007 173 189 x (Pubitemid 46829972)
2. E.E. Powell, J.R. Jonsson, and A.D. Clouston Steatosis: co-factor in other liver diseases Hepatology 42 2005 5 13 (Pubitemid 40911303)
3. M. Selzner, and P.A. Clavien Fatty liver in liver transplantation and surgery Semin. Liver Dis. 21 2001 105 113 (Pubitemid 32240490)
4. J.M. Clark The epidemiology of nonalcoholic fatty liver disease in adults J. Clin. Gastroenterol. 40 Suppl 1 2006 S5 S10
5. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
6. A.M. Diehl Genetic susceptibility to hepatic steatosis N Engl J. Med. 362 2010 1142 1143
7. M. Ricchi, M.R. Odoardi, L. Carulli, C. Anzivino, S. Ballestri, A. Pinetti, L.I. Fantoni, F. Marra, M. Bertolotti, S. Banni, A. Lonardo, N. Carulli, and P. Loria Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes J. Gastroenterol. Hepatol. 24 2009 830 840
8. H. Wobser, C. Dorn, T.S. Weiss, T. Amann, C. Bollheimer, R. Buttner, J. Scholmerich, and C. Hellerbrand Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells Cell Res. 19 2009 996 1005
9. A.M. Gressner, and R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets J. Cell. Mol. Med. 10 2006 76 99 (Pubitemid 44874293)
10. L.G. Cavin, R. Romieu-Mourez, G.R. Panta, J. Sun, V.M. Factor, S.S. Thorgeirsson, G.E. Sonenshein, and M. Arsura Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes Hepatology 38 2003 1540 1551 (Pubitemid 37466980)
11. C. Rodgarkia-Dara, S. Vejda, N. Erlach, A. Losert, W. Bursch, W. Berger, R. Schulte-Hermann, and M. Grusch The activin axis in liver biology and disease Mutat. Res. 613 2006 123 137 (Pubitemid 44750847)
12. M. Grusch, C. Drucker, B. Peter-Vorosmarty, N. Erlach, A. Lackner, A. Losert, D. Macheiner, W.J. Schneider, M. Hermann, N.P. Groome, W. Parzefall, W. Berger, B. Grasl-Kraupp, and R. Schulte-Hermann Deregulation of the activin/follistatin system in hepatocarcinogenesis J. Hepatol. 45 2006 673 680 (Pubitemid 44466665)
13. A. Yndestad, J.W. Haukeland, T.B. Dahl, K. Bjoro, I.P. Gladhaug, C. Berge, J.K. Damas, T. Haaland, E.M. Loberg, P. Linnestad, K. Birkeland, Z. Konopski, B. Halvorsen, R.K. Berge, and P. Aukrust A complex role of activin A in non-alcoholic fatty liver disease Am. J. Gastroenterol. 104 2009 2196 2205
14. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S. Lam, and G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J. Clin. Invest. 112 2003 91 100 (Pubitemid 38056380)
15. A. Schaffler, J. Scholmerich, and C. Buchler Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease Nat. Clin. Pract. Gastroenterol. Hepatol. 2 2005 273 280 (Pubitemid 40895403)
16. I. Wedemeyer, L.P. Bechmann, M. Odenthal, C. Jochum, G. Marquitan, U. Drebber, G. Gerken, R.K. Gieseler, H.P. Dienes, and A. Canbay Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C J. Hepatol. 50 2009 140 149
17. E. Bugianesi, U. Pagotto, R. Manini, E. Vanni, A. Gastaldelli, R. de Iasio, E. Gentilcore, S. Natale, M. Cassader, M. Rizzetto, R. Pasquali, and G. Marchesini Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity J. Clin. Endocrinol. Metab. 90 2005 3498 3504 (Pubitemid 41014319)
18. H. Ma, V. Gomez, L. Lu, X. Yang, X. Wu, and S.Y. Xiao Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease J. Gastroenterol. Hepatol. 24 2009 233 237
19. M. Nannipieri, F. Cecchetti, M. Anselmino, E. Mancini, G. Marchetti, A. Bonotti, S. Baldi, B. Solito, M. Giannetti, A. Pinchera, F. Santini, and E. Ferrannini Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis Obes. Surg. 19 2009 467 474
20. M. Neumeier, C. Hellerbrand, E. Gabele, R. Buettner, C. Bollheimer, J. Weigert, A. Schaffler, T.S. Weiss, M. Lichtenauer, J. Scholmerich, and C. Buechler Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis World J. Gastroenterol. 12 2006 5490 5494 (Pubitemid 44501807)
21. J. Weigert, M. Neumeier, J. Wanninger, F. Schober, D. Sporrer, M. Weber, A. Schramm, S. Wurm, F. Stogbauer, M. Filarsky, A. Schaffler, C. Aslanidis, J. Scholmerich, and C. Buechler Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes Cytokine 45 2009 86 91
22. M. Neumeier, J. Weigert, A. Schaffler, T. Weiss, S. Kirchner, S. Laberer, J. Scholmerich, and C. Buechler Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors Biochem. Biophys. Res. Commun. 334 2005 924 929 (Pubitemid 41033208)
23. J. Weigert, M. Neumeier, J. Wanninger, S. Wurm, A. Kopp, F. Schober, M. Filarsky, A. Schaffler, M. Zeitoun, C. Aslanidis, and C. Buechler Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes FEBS Lett. 582 2008 1777 1782
24. T.S. Weiss, S. Pahernik, I. Scheruebl, K.W. Jauch, and W.E. Thasler Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid J. Hepatol. 38 2003 476 482 (Pubitemid 36399251)
25. W.E. Thasler, T.S. Weiss, K. Schillhorn, P.T. Stoll, B. Irrgang, and K.W. Jauch Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany Cell Tissue Bank. 4 2003 49 56 (Pubitemid 37508457)
26. M. Neumeier, J. Weigert, A. Schaffler, T.S. Weiss, C. Schmidl, R. Buttner, C. Bollheimer, C. Aslanidis, J. Scholmerich, and C. Buechler Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro Biochem. Biophys. Res. Commun. 350 2006 731 735 (Pubitemid 44547907)
27. C.H. Tang, Y.C. Chiu, T.W. Tan, R.S. Yang, and W.M. Fu Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway J. Immunol. 179 2007 5483 5492
28. J. Wanninger, M. Neumeier, J. Weigert, S. Bauer, T.S. Weiss, A. Schaffler, C. Krempl, C. Bleyl, C. Aslanidis, J. Scholmerich, and C. Buechler Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways Am. J. Physiol. Gastrointest. Liver Physiol. 297 2009 G611 G618
29. J.M. Hui, A. Hodge, G.C. Farrell, J.G. Kench, A. Kriketos, and J. George Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40 2004 46 54 (Pubitemid 38868922)
30. G. Targher, L. Bertolini, L. Scala, F. Poli, L. Zenari, and G. Falezza Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals Clin. Endocrinol. (Oxf.) 61 2004 700 703 (Pubitemid 40006789)
31. D.J. Phillips, K.L. Jones, J.Y. Scheerlinck, M.P. Hedger, and D.M. de Kretser Evidence for activin A and follistatin involvement in the systemic inflammatory response Mol. Cell. Endocrinol. 180 2001 155 162 (Pubitemid 32651681)
32. S. Werner, and C. Alzheimer Roles of activin in tissue repair, fibrosis, and inflammatory disease Cytokine Growth Factor Rev. 17 2006 157 171 (Pubitemid 43816894)
33. E. Yan, F. Durazo, M. Tong, and K. Hong Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management Nutr. Rev. 65 2007 376 384 (Pubitemid 351804353)
34. T. Eldar-Geva, I.M. Spitz, N.P. Groome, E.J. Margalioth, and R. Homburg Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome Hum. Reprod. 16 2001 2552 2556 (Pubitemid 34007470)
35. T.A. Zografos, C. Liaskos, E.I. Rigopoulou, E. Togousidis, K. Makaritsis, A. Germenis, and G.N. Dalekos Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C Am. J. Gastroenterol. 103 2008 605 614 (Pubitemid 351406003)
36. T.S. Tsao, H.E. Murrey, C. Hug, D.H. Lee, and H.F. Lodish Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30) J. Biol. Chem. 277 2002 29359 29362 (Pubitemid 41079218)
37. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769 (Pubitemid 36735700)
38. S. Dasgupta, S. Bhattacharya, A. Biswas, S.S. Majumdar, S. Mukhopadhyay, and S. Ray NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance Biochem. J. 429 2010 451 462
39. A.V. Janorkar, K.R. King, Z. Megeed, and M.L. Yarmush Development of an in vitro cell culture model of hepatic steatosis using hepatocyte-derived reporter cells Biotechnol. Bioeng. 102 2009 1466 1474
40. R. Mishra, and M.S. Simonson Oleate induces a myofibroblast-like phenotype in mesangial cells Arterioscler. Thromb. Vasc. Biol. 28 2008 541 547
41. S.M. Rahman, I. Qadri, R.C. Janssen, and J.E. Friedman Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis J. Lipid Res. 50 2009 2193 2202
42. P.K. Hansson, A.K. Asztely, J.C. Clapham, and S.A. Schreyer Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability Biochim. Biophys. Acta 1684 2004 54 62 (Pubitemid 39140868)
43. F.P. Kuhajda Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 66 2006 5977 5980
44. T. Jarde, F. Caldefie-Chezet, N. Goncalves-Mendes, F. Mishellany, C. Buechler, F. Penault-Llorca, and M.P. Vasson Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies Endocr.-Relat. Cancer 16 2009 1197 1210
45. M. Zakikhani, R.J. Dowling, N. Sonenberg, and M.N. Pollak The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase Cancer Prev. Res. (Phila. Pa.) 1 2008 369 375